Skip to content

For research use only. Not for human consumption.

Research guide

Selank vs Semax: Research Comparison

Two synthetic heptapeptides that share a Pro-Gly-Pro tail but derive from different parent molecules. Here is how the published literature treats each as a research subject.

Author
A&A Wellness Editorial Team
Updated
Reading time
8 min read
A&A Wellness Selank 10mg and Semax 10mg research vials side by side on a soft gray surface

Selank and Semax are often mentioned in the same breath, and for understandable reasons. Both are short synthetic peptides, both carry the same three-amino-acid extension, and both have been studied largely by the same national research community.

They are not variations of one compound, though. Each is built on a different parent molecule, and the published literature has studied them in different experimental settings. This guide compares them as research subjects. A&A Wellness supplies both strictly for research use; they are not for human or veterinary use.

The Shared Design: A Pro-Gly-Pro Extension

Both peptides are constructed the same way: a short fragment of a naturally occurring peptide, extended at the C-terminus with Pro-Gly-Pro (PGP).

Why PGP? Short native peptides are typically broken down quickly by peptidases. The PGP extension is described in the literature as a way to increase stability against that degradation. It is the common structural thread between the two molecules and the main reason they are discussed together.

Side-by-Side Comparison

Selank Semax
Classification Synthetic heptapeptide Synthetic heptapeptide
Parent molecule Tuftsin (described as a “peptide analog of tuftsin”) ACTH fragment (described as “ACTH(4-7)PGP” and as an “ACTH(4-10) analog”)
Mechanism as described in literature Studied in relation to GABAergic signaling and neurotrophin (BDNF) content in rodent models Studied in relation to gene and protein expression in ischemia models and in neuroimaging of healthy volunteers
Typical experimental models Rodent stress, anxiety-behavior, and ethanol models Rodent cerebral ischemia models; resting-state fMRI in healthy volunteers
Research stage Mostly preclinical; limited human neuroimaging Preclinical plus limited human neuroimaging
US regulatory status Not FDA-approved Not FDA-approved; reviewed by FDA’s Pharmacy Compounding Advisory Committee in July 2026

Selank

What It Is

Selank is a synthetic heptapeptide that published studies describe as “a peptide analog of tuftsin.” Tuftsin is a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg); Selank extends it with the PGP sequence.

How It Has Been Studied

Most indexed Selank research uses rodent models. Examples include:

  • Stress and anxiety-behavior models. In a 2017 rat study in Behavioural Neurology, Kasian and colleagues used the elevated plus maze under unpredictable chronic mild stress. They reported that Selank combined with diazepam produced the largest reduction in anxiety-related behavior in that model (Kasian et al., 2017).
  • Ethanol models. Kolik and colleagues reported that, in rats given ethanol chronically, Selank was associated with preserved performance on object-recognition tasks and changes in BDNF content in the hippocampus and prefrontal cortex (Kolik et al., 2019).

A 2021 review in the Journal of Clinical Pharmacology grouped Selank with other agents that impact GABA receptors. The authors described it as poorly studied and noted that it was being sold to US consumers as a dietary supplement, which they flagged as a concern (Doyno et al., 2021).

Read the full profile: Selank. View the research material: Selank.

Semax

What It Is

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone (ACTH). Published work describes it as “ACTH(4-7)PGP”: the ACTH fragment Met-Glu-His-Phe extended with PGP. It is also commonly referred to as an ACTH(4-10) analog.

How It Has Been Studied

  • Cerebral ischemia models. In a 2021 study in the International Journal of Molecular Sciences, Sudarkina and colleagues profiled brain protein expression in a rat model of transient middle cerebral artery occlusion. They reported that Semax was associated with downregulation of MMP-9, c-Fos, and active JNK in cortex adjacent to the lesion (Sudarkina et al., 2021).
  • Human neuroimaging. Lebedeva and colleagues used resting-state fMRI in 24 healthy volunteers and reported differences in a subcomponent of the brain’s default mode network after intranasal Semax compared with placebo (Lebedeva et al., 2018).

Read the full profile: Semax. View the research material: Semax.

Where the Two Meet in the Literature

At least one study examined both peptides directly. Panikratova and colleagues performed resting-state fMRI in 52 healthy volunteers before and after administration of Selank, Semax, or placebo. They reported both general and compound-specific effects on functional connectivity between the right amygdala and the right temporal cortex (Panikratova et al., 2020).

What this does and does not show. A small, short-duration imaging study can show that two compounds produce measurably different signals. It cannot establish clinical effects. For researchers, its value is methodological: it shows the two peptides being treated as distinct experimental variables within one protocol.

Reading This Literature Critically

Geographic concentration. Most indexed research on both peptides comes from Russian groups and is published in a limited set of journals. That does not invalidate it, but independent replication is limited.

Model dependence. Rodent behavior models, such as the elevated plus maze, are standard tools, but findings in them do not translate directly to other species.

Small human samples. The human studies cited here are neuroimaging studies in healthy volunteers with small samples, not controlled clinical trials of any outcome.

Regulatory Status

  • FDA approval. Neither Selank nor Semax is an FDA-approved drug.
  • Compounding review. FDA’s page on bulk drug substances that may present significant safety risks lists both “Selank acetate” and “Semax (heptapeptide)” among nominations that were previously in category 2 and were later withdrawn by the nominators (FDA). Semax was among seven peptides reviewed at FDA’s Pharmacy Compounding Advisory Committee meeting on July 24, 2026, in connection with possible inclusion on the section 503A bulks list (FDA). Advisory committee recommendations are not binding, and compounding rules apply to pharmacies, not to research-reagent suppliers.

Our US regulatory overview explains these categories in more detail.

Handling and Documentation

Both peptides are commonly supplied lyophilized. See lyophilized peptides explained and the peptide storage guide for general conventions. Confirm identity against the batch documentation using our guide to reading a COA. Read more about our standards on the Quality page.

Browse Selank, Semax, or the full research peptides category.

Sources

  1. Kasian A, et al. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats. Behav Neurol. 2017
  2. Kolik LG, et al. Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating BDNF Content in Rats. Bull Exp Biol Med. 2019
  3. Sudarkina OY, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. Int J Mol Sci. 2021
  4. Lebedeva IS, et al. Effects of Semax on the Default Mode Network of the Brain. Bull Exp Biol Med. 2018
  5. Panikratova YR, et al. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020
  6. Doyno CR, et al. Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. J Clin Pharmacol. 2021
  7. FDA. July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee
  8. FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks

FAQ

Selank vs Semax: common questions

Both are synthetic peptides built by attaching a Pro-Gly-Pro (PGP) sequence to a short fragment of a naturally occurring peptide. The PGP extension is generally described in the literature as a way to increase resistance to enzymatic breakdown.

Selank is described in published studies as a peptide analog of tuftsin, a tetrapeptide associated with immunoglobulin G. Semax is described as an analog of an ACTH fragment, specifically ACTH(4-7) extended with PGP, and is often referred to as an ACTH(4-10) analog.

No. Neither Selank nor Semax is an FDA-approved drug in the United States. Both are sold by A&A Wellness strictly as research-use-only materials that are not for human or veterinary use.

The majority of indexed studies on both peptides come from Russian research groups, many published in journals such as the Bulletin of Experimental Biology and Medicine. Much of that work uses rodent models, with a smaller number of neuroimaging studies in healthy volunteers.

This guide compares them only as laboratory research subjects. They derive from different parent molecules and have been studied in different experimental contexts, so the appropriate choice depends entirely on the research question being asked.

In the catalog

Related research products

A&A Wellness Selank 10mg research peptide vial with black flip cap

Research Peptides

Selank

  • 10mg

$60.00

View
A&A Wellness Semax 10mg research peptide vial with white label

Research Peptides

Semax

  • 10mg

$60.00

View

Keep reading

Related articles

All education
  • Open reference book with a black ribbon bookmark on a white desk

    Guide12 min read

    Peptide Research Glossary

    Plain-language definitions of more than 50 terms you will meet on product pages, certificates of analysis, and research papers, from acetate salt to TFA.

    Read
  • Stack of plain documents and a black binder with a silver clip on a white desk

    Guide11 min read

    Research Peptides: US Regulatory Overview

    General information on how US law treats research-use-only peptides: FDA's intended-use standard, the 2026 compounding review, advertising rules, state considerations, and anti-doping lists. Not legal advice.

    Read

Research use only

From the library to the catalog

Browse research products with clear specifications and storage information.

  • 99% purity guaranteed
  • Lab tested in the USA
  • Research use only
  • Discreet packaging
  • Clear specifications
  • Responsive support
Shop productsCart0